name: Buruli ulcer
category: Infectious Disease
description: >-
  Buruli ulcer is an indolent necrotizing disease of the skin and subcutaneous
  tissues caused by Mycobacterium ulcerans, leading to deep ulcerations and
  disability.
disease_term:
  term:
    id: MONDO:0000327
    label: Buruli ulcer disease
  preferred_term: Buruli ulcer disease
parents:
- Bacterial Infection
- Neglected tropical disease
infectious_agent:
- name: Mycobacterium ulcerans
  infectious_agent_term:
    preferred_term: Mycobacterium ulcerans
    term:
      id: NCBITaxon:1809
      label: Mycobacterium ulcerans
  description: Slow-growing mycobacterium that produces mycolactone toxin.
  evidence:
  - reference: PMID:21240839
    supports: SUPPORT
    snippet: "Buruli ulcer (BU), caused by Mycobacterium ulcerans"
    explanation: The abstract identifies M. ulcerans as the cause of Buruli ulcer.
pathophysiology:
- name: Mycolactone-mediated tissue destruction
  description: Mycolactone toxin leads to subcutaneous tissue destruction and immunosuppression, producing deep ulcers.
  evidence:
  - reference: PMID:30429139
    supports: SUPPORT
    snippet: "Mycobacterium ulcerans produces a mycolactone toxin that leads to subcutaneous tissue destruction and immunosuppression, resulting in deep ulcerations"
    explanation: The abstract links mycolactone to tissue destruction and ulceration.
phenotypes:
- name: Skin ulcer
  category: Dermatologic
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Skin ulcer
    term:
      id: HP:0200042
      label: Skin ulcer
  evidence:
  - reference: PMID:19362692
    supports: SUPPORT
    snippet: "Buruli ulcer is an indolent necrotizing disease of the skin, subcutaneous tissue, and bone"
    explanation: The disease is defined by necrotizing skin disease with ulceration.
treatments:
- name: Antimycobacterial therapy
  description: Antimycobacterial therapy is effective for early lesions.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:21240839
    supports: SUPPORT
    snippet: "While antimycobacterial therapy is often effective for the earliest nodular or ulcerative lesions"
    explanation: The abstract describes antimycobacterial therapy effectiveness in early lesions.
- name: Surgical management
  description: Surgery may be required for advanced ulcerated lesions.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
  evidence:
  - reference: PMID:21240839
    supports: SUPPORT
    snippet: "for advanced ulcerated lesions, surgery is sometimes necessary."
    explanation: The abstract notes surgery for advanced lesions.
